Xometry Inc
For the period ended Mar 31, 2024. Filed May 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 9, 2024
XMTR$119.31-1.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)
Condensed Consolidated Statements of Changes in Stockholders’Equity
Three months ended March 31, 2024 and 2023
| Class A - Common Stock · Class B - Common Stock · Additional Paid-In · Accumulated Other Comprehensive · Accumulated · Total Stockholders' · Noncontrolling · Total | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | Capital | Income | Deficit | Equity | Interest | Equity | |
| Balance, December 31, 2023 | 45,489,379 | $— | 2,676,154 | $— | $648,317 | $855 | $(319,872) | 329,300 | $1,119 | 330,419 |
| Exercise of common stock options | 120,481 | — | — | — | 1,233 | — | — | 1,233 | — | 1,233 |
| Vesting of restricted stock units | 359,911 | — | — | — | — | — | — | — | — | — |
| Shared issued in business combination | 21,083 | — | — | — | 625 | — | — | 625 | — | 625 |
| Donated common stock | 20,133 | — | — | — | 343 | — | — | 343 | — | 343 |
| Stock based compensation | — | — | — | — | 6,036 | — | — | 6,036 | — | 6,036 |
| Comprehensive loss | ||||||||||
| Foreign currency translation | — | — | — | — | — | (474) | — | (474) | 17 | (457) |
| Net loss | — | — | — | — | — | — | (16,616) | (16,616) | 12 | (16,604) |
| Total comprehensive loss | — | — | — | — | — | — | — | (17,090) | 29 | (17,061) |
| Balance, March 31, 2024 | 46,010,987 | $— | 2,676,154 | $— | $656,554 | $381 | $(336,488) | $320,447 | $1,148 | $321,595 |
| Balance, December 31, 2022 | 44,822,264 | $— | 2,676,154 | $— | $623,081 | $28 | $(249,366) | $373,743 | $1,090 | $374,833 |
| Exercise of common stock options | 82,909 | — | — | — | 483 | — | — | 483 | — | 483 |
| Vesting of restricted stock units | 169,446 | — | — | — | — | — | — | — | — | — |
| Shared issued in business combination | 3,562 | — | — | — | 180 | — | — | 180 | — | 180 |
| Donated common stock | 20,133 | — | — | — | 370 | — | — | 370 | — | 370 |
| Stock based compensation | — | — | — | — | 4,694 | — | — | 4,694 | — | 4,694 |
| Comprehensive loss | ||||||||||
| Foreign currency translation | — | — | — | — | — | 131 | — | 131 | 4 | 135 |
| Net loss (income) | — | — | — | — | — | — | (18,344) | (18,344) | 1 | (18,343) |
| Total comprehensive loss | — | — | — | — | — | — | — | (18,213) | 5 | (18,208) |
| Balance, March 31, 2023 | 45,098,314 | $— | 2,676,154 | $— | $628,808 | $159 | $(267,710) | $361,257 | $1,095 | $362,352 |
Condensed Consolidated Statements of
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.